A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
CONCLUSION: The combination of daptomycin plus fosfomycin may be an effective therapeutic option for MRSA infection.
PMID: 31060599 [PubMed - in process]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research
More News: Cubicin | Drugs & Pharmacology | Infectious Diseases | Linezolid | MRSA | Staphylococcus Aureus | Study | Superbugs | Toxicology | Zyvox